Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
59 /100
COMPONENT-LIMITED
Score updated Nov 20, 2026

ACRV — Acrivon Therapeutics, Inc. Dilution Risk Tracker

Track ACRV dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — higher scores indicate higher risk of share dilution.

Not financial advice. Do your own research before making any investment decisions.

Track ACRV — Get alerts when the score changes →

As of November 20, 2026, Acrivon Therapeutics, Inc. (ACRV) has a DilutionWatch DilutionScore of 59/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Acrivon Therapeutics, Inc. has a market capitalization of $60.08M, 42.91M shares outstanding, 45 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $300.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

Offering Ability
96
Cash Runway
40
Float Risk—
Warrant Exposure
40
Convertible Debt
40

Dilution Forecast

Forecast data not available for this ticker.

Market Data

Market Cap$60.08M
Shares Outstanding42.91M
Float16.87M
Cash$77.75M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore59/100DilutionWatch score record
Shares Outstanding42.91MVerified float table or market cache
Public Float16.87MVerified float table or market cache
Market Cap$60.08MMarket data cache
Cash Runway13.6 monthsDilutionWatch score inputs
Shelf Capacity$300.00MSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: FORM 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

ACRV SEC Filing Activity — Last 12 Months

Shares outstanding reported by ACRV on the cover page of its latest 10-K/10-Q: 42.91M as of November 10, 2026.

DilutionWatch recorded 1 registration or prospectus document for ACRV (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
S-3shelf registration1Nov 16, 2026
8-Kcurrent report (material event)5Nov 20, 2026
10-Qquarterly report1Nov 16, 2026
SC 13G/Aamended passive >5% holder filing1Aug 13, 2026
4insider transaction13Nov 19, 2026

Institutional Holdings

QoQ: ↓ 0.3% shares (2026Q1 vs prior)
45 institutional holders · 17.57M shares
#1 RA CAPITAL MANAGEMENT, L.P. 8.34M shares
#2 Sands Capital Alternatives, LLC 2.12M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 1.44M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.80M
Days to Cover11.4
% of Float10.7%
FINRA data as of Oct 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-05-13
Form 4 INSIDER TRANSACTION 2026-11-17
Form 4 INSIDER TRANSACTION 2026-11-17
Form 4 INSIDER TRANSACTION 2026-11-17
Form 4 INSIDER TRANSACTION 2026-11-17
Full SEC filing analysis available with free account →

Recent News

Factual ACRV Dilution Snapshot

Acrivon Therapeutics, Inc. (ACRV) has a DilutionScore of 59/100, rated High dilution risk. Score date: November 20, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ACRV's DilutionScore is currently 59/100 (High risk), with 2 score changes tracked over 89 days. The score improved from 45/100 (Medium risk).

Period Score Risk Level Duration
Nov 17 – Nov 20, 202659/100HIGH4 days
Nov 16, 202645/100MEDIUM1 day
Aug 24 – Nov 15, 202642/100MEDIUM84 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ACRV shares outstanding have increased 0.1% from 42.85M (Nov 2026) to 42.91M (Nov 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Nov 21, 202642.91M16.87M—
Nov 18, 202642.91M16.87M—
Nov 10, 202642.85M16.87M—

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ACRV Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ACRV files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ACRV — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 7,727+ tracked stocks →

Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for ACRV
ACRV FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.